Colorectal cancer

Victor Moreno Aguado / Ramon Salazar Soler

PRINCIPAL INVESTIGATORS
  • Mercedes Martinez Villacampa
  • Cristina Santos Vivas
  • Gemma Soler Gonzalez
  • Rebeca Sanz Pamplona
  • Eric Duell
CLINICAL RESEARCHERS
  • Francisco Rodriguez Moranta
  • Esther Kreisler Moreno
  • Domenico Nicola Fraccalviri
  • Jose Carlos Ruffinelli Rodriguez
  • Nuria Mulet Margalef
  • Albert Sueiras Gil
  • Ferran Losa Gaspa
POSTDOCTORAL RESEARCHERS
  • Mireia Obon Santacana
  • Gemma Ibáñez Sanz
  • Marisa Martinez Muñoz
  • David Bars Cortina
  • Lourdes Criado Mesas
  • Elies Ramón Gurrea
  • Miguel Socolovski Visiedo
PREDOCTORAL RESEARCHERS
  • Sandra Garcia Mulero
  • Joan Mas Lloret
  • Virginia Diez Obrero
  • Sara Hijazo Pechero
  • Ainhoa García Serrano
  • JBlanca Rius Sansalvador
  • Lois Riobó Mayo
SCIENTIFIC SUPPORT
  • Ferran Moratalla Navarro
  • Elisabet Guino Domenech
  • Daniel Azuara Garcia
  • Susana Lopez Ruiz
  • Anna Diez Villanueva
  • Carmen Rosa Atencia Rojas
MANAGEMENT SUPPORT
  • Olga Lopez Ciercoles
  • Paula Ximena Fernandez Calotti
  • Claudia Lorena Latorre Gaviria
  • Adelaida Piera Sancerni
  • Helena Peña Paris
  • Francesc Alarcon Moral
  • Jordi Vea Barbany
  • Silvia Murcia Muñoz
  • Andrea Ruiz Valderrama
  • Ana Maria Lopez Muñoz
Cancer
Oncobell

Scientific production

75

PAPERS

Impact factor: 651,195

23 PUBLICATIONS IN FIRST DECILE

59 PUBLICATIONS IN FIRST QUARTILE

56 PUBLICATIONS IN OPEN ACCESS

Selected publications:

  • Fuentes P, Pelletier J, Martinez Herráez C, Diez Obrero V, Iannizzotto F, Rubio T, Garcia Cajide M, Menoyo S, Moreno V, Salazar R, Tauler A, Gentilella A. The 40S-LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity. Sci Adv. 2021;7(48):doi:10.1126/sciadv.abg9275. IF:14,14.
  • Diez Villanueva A, Jorda M, Carreras Torres R, Alonso H, Cordero D, Guino E, Sanjuan X, Santos C, Salazar R, Sanz Pamplona R, Moreno V. Identifying causal models between genetically regulated methylation patterns and gene expression in healthy colon tissue. Clin Epigenetics. 2021;13(1):162-162. doi:10.1186/s13148-021-01148-9. IF:6,55.
  • Carmona Bayonas A, Jimenez Fonseca P, Valenti V, Salazar R. Bayesian interpretation of the ESMO guideline for localized colorectal cancer: a better IDEA. Ann. Oncol. 2021;32(7):938-939. doi:10.1016/j.annonc.2021.03.003. IF:32,98.
  • Ruffinelli,JCC,Guino,E,Cid,ND,Navarro,M,Moreno,V,Vidal,JMB,Salazar,R,Vivas,C.Early-onset colorectal cancer: 10-year cases documented in a comprehensive cancer centre illustrate the importance of a growing oncological problem.Ann. Oncol.2021.32575-575.doi:10.1016/j.annonc.2021.08.1013.
  • Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP; RAPIDO collaborative investigators*(R. Salazar). Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. IF:41,32.

Research highlights

PROJECTS

19 Competitive projects
19 Non-competive projects
28 clinical trials

PUBLISHED WORKS

4 theses

NETWORKS

CIBERESP
CIBERONC

Selected projects

  • 20MAR011. Validation of a predictive molecular signature in Neuroendocrine Tumors. (201938-30). CENTRE FOR APPLIED RESEARCH ON CANCER (ARC-NET); FUNDACIO IDIBELL; FUNDACIÓ LA MARATÓ DE TV3; INSTITUTE OF CANCER RESEARCH. 2020-2023. PI: SALAZAR SOLER,RAMON
  • 21FIS026. ¿Cómo influye el microambiente inmune en el patrón de diseminación mestatásica y supervivencia en pacientes con cáncer colorrectal? Estudio de tumores primarios y mestastásicos apareados. (PI20/00767). ISCIII. 2021-2023. PI: SANTOS VIVAS,CRISTINA.
  • 18PSJ019. Genetic and metabolomics screening towards the precision medicine in cancer prevention. (GCTRA18022MORE). AECC; ASOCIACION INSTITUTO BIODONOSTIA; FISABIO; FUND.SANT JOAN DE DEU; FUNDACIO IDIBELL; FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA – FFIS DE LA REGION DE MURCIA; INST. D’INVESTIGACIÓ BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI); INSTITUT CATALA D’ONCOLOGIA; INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA; ISCIII; ISGLOBAL; UNIVERSIDAD DE CANTABRIA; UNIVERSIDAD DE GRANADA; UNIVERSIDAD DE HUELVA; UNIVERSIDAD DE LEON; UNIVERSIDAD DE OVIEDO. 2018-2024. PI: MORENO AGUADO,VICTOR.
  • 20FIS019. Refining the consensus molecular subtypes classification: prognostic and therapeutic implications in stage II colon cancer. (PI19/01903). ISCIII. 2020-2022. PI: SALAZAR SOLER,RAMON.
  • 18FIS005. Estudio de las interacciones microbioma-anfitrión para la prevención del cáncer colorrectal (Colonbiome). (PI17/00092). ISCIII. 2018-2022. PI: MORENO AGUADO,VICTOR.